OBJECTIVE: A multicentre evaluation was performed to assess two rapid low-cost methods, MTT (3-[4.5-dimethylthiazol-2-yl]-2.5-diphenyltetrazolium bromide) and resazurin assays, for testing the susceptibility of Mycobacterium tuberculosis to the first-line anti-tuberculosis drugs rifampicin (RMP), isoniazid (INH), ethambutol (EMB) and streptomycin (SM). METHODS: Thirty coded M. tuberculosis strains were sent to seven laboratories located in Latin America, representing six countries. Each site performed the colorimetric assays, MTT and resazurin, blind for the first-line drugs RMP, INH, EMB and SM. The minimum inhibitory concentration results obtained were compared to the conventional proportion method on Lowenstein-Jensen medium. RESULTS: After establishing the breakpoint concentrations, excellent results were obtained for RMP, INH and EMB, with levels of specificity and sensitivity of between 96% and 99%. CONCLUSION: MTT and resazurin assays are promising, accessible new alternative methods for middle- and low-resource countries that need low-cost methods to perform rapid susceptibility testing of M. tuberculosis to key anti-tuberculosis drugs.
OBJECTIVE: A multicentre evaluation was performed to assess two rapid low-cost methods, MTT (3-[4.5-dimethylthiazol-2-yl]-2.5-diphenyltetrazolium bromide) and resazurin assays, for testing the susceptibility of Mycobacterium tuberculosis to the first-line anti-tuberculosis drugs rifampicin (RMP), isoniazid (INH), ethambutol (EMB) and streptomycin (SM). METHODS: Thirty coded M. tuberculosis strains were sent to seven laboratories located in Latin America, representing six countries. Each site performed the colorimetric assays, MTT and resazurin, blind for the first-line drugs RMP, INH, EMB and SM. The minimum inhibitory concentration results obtained were compared to the conventional proportion method on Lowenstein-Jensen medium. RESULTS: After establishing the breakpoint concentrations, excellent results were obtained for RMP, INH and EMB, with levels of specificity and sensitivity of between 96% and 99%. CONCLUSION:MTT and resazurin assays are promising, accessible new alternative methods for middle- and low-resource countries that need low-cost methods to perform rapid susceptibility testing of M. tuberculosis to key anti-tuberculosis drugs.
Authors: Edward A Nardell; Scott J Bucher; Philip W Brickner; Charles Wang; Richard L Vincent; Kathleen Becan-McBride; Mark A James; Max Michael; James D Wright Journal: Public Health Rep Date: 2008 Jan-Feb Impact factor: 2.792
Authors: Yap Boum; Patrick Orikiriza; Gabriel Rojas-Ponce; Margarita Riera-Montes; Daniel Atwine; Margaret Nansumba; Joel Bazira; Eleanor Tuyakira; Pierre De Beaudrap; Maryline Bonnet; Anne-Laure Page Journal: J Clin Microbiol Date: 2013-05-08 Impact factor: 5.948
Authors: Catherine Vilchèze; Yossef Av-Gay; S Whitney Barnes; Michelle H Larsen; John R Walker; Richard J Glynne; William R Jacobs Journal: Antimicrob Agents Chemother Date: 2011-06-27 Impact factor: 5.191
Authors: Catherine Vilchèze; Anthony D Baughn; JoAnn Tufariello; Lawrence W Leung; Mack Kuo; Christopher F Basler; David Alland; James C Sacchettini; Joel S Freundlich; William R Jacobs Journal: Antimicrob Agents Chemother Date: 2011-05-31 Impact factor: 5.191
Authors: Feng Wang; Paras Jain; Gulcin Gulten; Zhen Liu; Yicheng Feng; Krishna Ganesula; Alifiya S Motiwala; Thomas R Ioerger; David Alland; Catherine Vilchèze; William R Jacobs; James C Sacchettini Journal: Antimicrob Agents Chemother Date: 2010-06-21 Impact factor: 5.191
Authors: Jozef Stec; Catherine Vilchèze; Shichun Lun; Alexander L Perryman; Xin Wang; Joel S Freundlich; William Bishai; William R Jacobs; Alan P Kozikowski Journal: ChemMedChem Date: 2014-08-27 Impact factor: 3.466